These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35384693)

  • 1. TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein.
    Zhang M; Wang X; Hu L; Zhang Y; Zheng H; Wu H; Wang J; Luo L; Xiao H; Qiao C; Li X; Huang W; Wang Y; Feng J; Chen G
    Microbiol Spectr; 2022 Jun; 10(3):e0221221. PubMed ID: 35384693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture.
    Ruedas JB; Ladner JT; Ettinger CR; Gummuluru S; Palacios G; Connor JH
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency.
    Ueda MT; Kurosaki Y; Izumi T; Nakano Y; Oloniniyi OK; Yasuda J; Koyanagi Y; Sato K; Nakagawa S
    Genes Cells; 2017 Feb; 22(2):148-159. PubMed ID: 28084671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion.
    Fels JM; Bortz RH; Alkutkar T; Mittler E; Jangra RK; Spence JS; Chandran K
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.
    Hoffmann M; Crone L; Dietzel E; Paijo J; González-Hernández M; Nehlmeier I; Kalinke U; Becker S; Pöhlmann S
    J Virol; 2017 May; 91(9):. PubMed ID: 28228590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.
    Dietzel E; Schudt G; Krähling V; Matrosovich M; Becker S
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.
    Brunton B; Rogers K; Phillips EK; Brouillette RB; Bouls R; Butler NS; Maury W
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0006983. PubMed ID: 31242184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic.
    Diehl WE; Lin AE; Grubaugh ND; Carvalho LM; Kim K; Kyawe PP; McCauley SM; Donnard E; Kucukural A; McDonel P; Schaffner SF; Garber M; Rambaut A; Andersen KG; Sabeti PC; Luban J
    Cell; 2016 Nov; 167(4):1088-1098.e6. PubMed ID: 27814506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical Basis for Increased Activity of Ebola Glycoprotein in the 2013-16 Epidemic.
    Wang MK; Lim SY; Lee SM; Cunningham JM
    Cell Host Microbe; 2017 Mar; 21(3):367-375. PubMed ID: 28238624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry.
    Rhein BA; Brouillette RB; Schaack GA; Chiorini JA; Maury W
    J Virol; 2016 Jul; 90(13):6097-6111. PubMed ID: 27122575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity.
    Acciani MD; Lay Mendoza MF; Havranek KE; Duncan AM; Iyer H; Linn OL; Brindley MA
    J Virol; 2021 Sep; 95(20):e0116521. PubMed ID: 34319156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway.
    Ruedas JB; Arnold CE; Palacios G; Connor JH
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.
    Lennemann NJ; Dillard J; Ruggio N; Cooney AL; Schaack GA; Davey RA; Maury W
    J Virol; 2021 Aug; 95(18):e0107321. PubMed ID: 34232742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry.
    Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
    Shrivastava-Ranjan P; Flint M; Bergeron É; McElroy AK; Chatterjee P; Albariño CG; Nichol ST; Spiropoulou CF
    mBio; 2018 May; 9(3):. PubMed ID: 29717011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.
    Usami K; Matsuno K; Igarashi M; Denda-Nagai K; Takada A; Irimura T
    Biochem Biophys Res Commun; 2011 Apr; 407(1):74-8. PubMed ID: 21362405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.
    Kuroda M; Fujikura D; Nanbo A; Marzi A; Noyori O; Kajihara M; Maruyama J; Matsuno K; Miyamoto H; Yoshida R; Feldmann H; Takada A
    J Virol; 2015 Jun; 89(12):6481-93. PubMed ID: 25855742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles.
    Li H; Yu F; Xia S; Yu Y; Wang Q; Lv M; Wang Y; Jiang S; Lu L
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
    Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
    J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.
    Martinez O; Ndungo E; Tantral L; Miller EH; Leung LW; Chandran K; Basler CF
    J Virol; 2013 Mar; 87(6):3324-34. PubMed ID: 23302883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.